Cargando…
Druggability for COVID-19: in silico discovery of potential drug compounds against nucleocapsid (N) protein of SARS-CoV-2
The coronavirus disease 2019 is a contagious disease and had caused havoc throughout the world by creating widespread mortality and morbidity. The unavailability of vaccines and proper antiviral drugs encourages the researchers to identify potential antiviral drugs to be used against the virus. The...
Autores principales: | Ray, Manisha, Sarkar, Saurav, Rath, Surya Narayan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korea Genome Organization
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808868/ https://www.ncbi.nlm.nih.gov/pubmed/33412759 http://dx.doi.org/10.5808/GI.2020.18.4.e43 |
Ejemplares similares
-
Presentation of potential genes and deleterious variants associated with non-syndromic hearing loss: a computational approach
por: Ray, Manisha, et al.
Publicado: (2022) -
A hybrid structure determination approach to investigate the druggability of the nucleocapsid protein of SARS-CoV-2
por: Padroni, Giacomo, et al.
Publicado: (2023) -
Drug Target Identification and Elucidation of Natural Inhibitors for Bordetella petrii: An In Silico Study
por: Rath, Surya Narayan, et al.
Publicado: (2016) -
SARS-CoV-2 nucleocapsid and Nsp3 binding: an in silico study
por: Khan, Muhammad Tahir, et al.
Publicado: (2020) -
In-silico screening to delineate novel antagonists to SARS-CoV-2 nucleocapsid protein
por: Shahanshah, Mohd Fardeen Husain, et al.
Publicado: (2022)